Pathogen

  • Campylobacter jejuni or Campylobacter coli
  • Largely a foodborne disease.
  • The organism inhabits the intestinal tracts of a wide range of animal hosts, notably poultry; contamination from these sources can lead to foodborne disease. 
  • Campylobacter infection can also be transmitted via water-borne outbreaks and direct contact with animals or animal products.

Natural history

  • The mean incubation period is three days
  • Early symptoms include abrupt onset of abdominal pain and diarrhea.
  • The acute illness is characterized by cramping periumbilical abdominal pain and diarrhea.
  • Patients frequently report ten or more bowel movements per day.
  • Bloody stools are observed on the second or third day of diarrhea in about 15 percent of adults; in children, bloody stools may be present in more than half of cases.
  • Diarrhea is self-limited and lasts for a mean of seven days.

Associations and Complications

Pseudoappendicitis

  • Severe abdominal pain prior to onset of diarrhea can mimic acute appendicitis.
  • In some cases, diarrhea is absent (this is most frequently observed among children aged 6 to 15 years).
  • The pain is caused by acute ileocecitis.
  • On clinical examination, tenderness may be observed; rebound tenderness and guarding are usually absent.

Colitis

  • Campylobacter infection usually starts in the jejunum and ileum and progresses distally to affect the cecum and colon.
  • In some patients present with acute colitis and bloody diarrhea, which can mimic the acute colitis of inflammatory bowel disease (IBD)

Reactive arthritis

  • The Reactive arthritis associated with Campylobacter enteritis is similar to arthritis that can occur following Salmonella, Shigella, and other bacterial diarrheal infections.

Guillain-Barré syndrome

  • C. jejuni infection has been established as a trigger of GBS, an acute immune-mediated polyneuropathy

Treatment

  • Supportive care − Campylobacter infection is usually a mild, self-limited infection.
  • For patients with severe disease or risk for severe disease, treatment with Azithromycin